1. Home
  2. Companies
  3. Supernus Pharmaceuticals
  4. Financial Ratios
  5. Operating Cycle
Supernus Pharmaceuticals logo
Supernus Pharmaceuticals SUPN
$ 45.66 2.65%

Quarterly report 2026-Q1
added 05-05-2026

report update icon

Supernus Pharmaceuticals Operating Cycle 2011-2026 | SUPN

Annual Operating Cycle Supernus Pharmaceuticals

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
492 387 461 457 418 341 665 702 470 582 611 904 2.53 K - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
2.53 K 341 694

Quarterly Operating Cycle Supernus Pharmaceuticals

2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
517 - 438 332 388 - 420 446 519 - 488 487 447 - 379 469 533 - 382 283 394 - 289 627 933 79.3 582 677 749 81 648 730 669 67.7 424 464 597 60.8 66.7 73.4 69.6 54.1 60.1 66.3 68.5 50.5 70.2 57.1 113 44.6 367 1.64 K 1.57 K 21.4 251 - 28.1 139 - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.64 K 21.4 381

Operating Cycle of other stocks in the Biotechnology industry

Issuer Operating Cycle Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
 		3.11 K - 5743.5 % $ 69.7 M canadaCanada
Compugen Ltd. Compugen Ltd.
CGEN
 		400 $ 2.02 -0.98 % $ 189 M israelIsrael
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
 		1.94 K - 1.35 % $ 17.8 M chinaChina
Coherus BioSciences Coherus BioSciences
CHRS
 		656 $ 1.42 - $ 166 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
 		186 - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
 		271 - - $ 866 M chinaChina
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
 		2.1 K - - $ 2.18 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		12.8 - - $ 40.3 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
 		1.73 - - $ 2.17 B usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
 		206 - - $ 96.9 B britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		32 - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
 		245 - -18.52 % $ 27.3 M britainBritain
Affimed N.V. Affimed N.V.
AFMD
 		31.4 - -34.95 % $ 21.5 M germanyGermany
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
 		1.1 K $ 51.48 -0.23 % $ 4.63 B schweizSchweiz
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
 		104 - - - russiaRussia
Celyad Oncology SA Celyad Oncology SA
CYAD
 		64.4 - - $ 12.5 M belgiumBelgium
Berkeley Lights Berkeley Lights
BLI
 		349 - -7.31 % $ 87 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
 		321 $ 29.6 3.64 % $ 1.97 B usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
 		47.6 - - $ 344 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		61.7 - - $ 7.46 M israelIsrael
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
 		185 - -4.36 % $ 27 M usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
 		235 $ 14.57 -0.21 % $ 209 M usaUSA
Advaxis Advaxis
ADXS
 		3.28 K - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
 		115 - 5.93 % $ 314 M canadaCanada
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		126 - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		17.9 - 1.93 % $ 17.4 M usaUSA
Aptinyx Aptinyx
APTX
 		46.9 - -39.0 % $ 4.57 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		40.8 - -0.23 % $ 916 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
 		291 $ 22.79 5.8 % $ 2.9 B usaUSA